RT Journal Article
SR Electronic
T1 Effects of Home-Based EEG Neurofeedback Training as a Non-Pharmacological Intervention for Parkinson’s Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.19.24303031
DO 10.1101/2024.02.19.24303031
A1 Cooke, Andrew
A1 Hindle, John
A1 Lawrence, Catherine
A1 Bellomo, Eduardo
A1 Pritchard, Aaron W.
A1 MacLeod, Catherine A.
A1 Martin-Forbes, Pam
A1 Jones, Sally
A1 Bracewell, Martyn
A1 Linden, David E. J.
A1 Mehler, David M. A.
YR 2024
UL http://medrxiv.org/content/early/2024/02/22/2024.02.19.24303031.abstract
AB Aberrant movement-related cortical activity has been linked to impaired motor function in Parkinson’s disease (PD). Dopaminergic drug treatment can restore these, but dosages and long-term treatment are limited by adverse side-effects. This experiment reports the first study of home-based electroencephalographic (EEG) neurofeedback training as a non-pharmacological candidate treatment for PD. Sixteen people with PD received six home visits comprising symptomology self-reports, a standardised motor assessment, and a precision handgrip force production task while EEG was recorded (visits 1, 2 and 6); and 3 × 1-hr EEG neurofeedback training sessions to reduce EEG high-alpha power before initiating handgrip movements (visits 3 to 5). Participants successfully learned to self-regulate movement-related alpha rhythms, and this appeared to expedite the initiation of precision movements. There was no evidence of wider symptomology reduction. Interviews indicated that the intervention was well-received. We conclude that home-based neurofeedback for people with PD is feasible and warrants further research.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN16783092Clinical Protocols https://www.isrctn.com/ISRCTN16783092 Funding StatementThis project was funded by Betsi Cadwaladr University Health Board Pathway to Portfolio award 195863.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Health Service Wales Research Ethics Committee 4 (Ref 16/WA/0115) and from Bangor University School of Psychology Human Research Ethics Committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets analysed during the current study are available from the corresponding author on reasonable request.